Related Experiment Video
Updated: Aug 14, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Polysaccharide vaccines: determinants of clinical efficacy
1Baylor College of Medicine, Houston USA.
Abstract:
Many common bacteria cause disease because their polysaccharide capsules prevent phagocytosis. Antibody directed against these capsules is the basis for some of the most effective bacterial vaccines. Nevertheless, many diseases caused by such bacteria continue to cause serious morbidity. Recent findings indicate that several previously unrecognized factors (most notably, genetics) determine responsiveness to capsular polysaccharides.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Related Concept Videos
Vaccinations
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Vaccine Production
Determinants of Bacterial Pathogenicity and Virulence
Vaccines
Poliomyelitis